[IPO Chat] Ingenia Therapeutics “We will establish a position in the vascular disease treatment market”

(Seoul = Yonhap News) Reporter Jeong Hoe-in = CEO Han Sang-yeol of Ingenia Therapeutics, which is seeking listing on KOSDAQ, said on the 14th, "With this listing, clinical development and pipeline...